83 related articles for article (PubMed ID: 9029109)
1. Regulation of class I-restricted epitope processing by local or distal flanking sequence.
Yellen-Shaw AJ; Eisenlohr LC
J Immunol; 1997 Feb; 158(4):1727-33. PubMed ID: 9029109
[TBL] [Abstract][Full Text] [Related]
2. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein.
Yellen-Shaw AJ; Wherry EJ; Dubois GC; Eisenlohr LC
J Immunol; 1997 Apr; 158(7):3227-34. PubMed ID: 9120278
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
Brett SJ; Rhodes J; Liew FY; Tite JP
J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the contribution of CTL epitopes in the immunobiology of morbillivirus infection.
Beauverger P; Cardoso AI; Daviet L; Buckland R; Wild TF
Virology; 1996 May; 219(1):133-9. PubMed ID: 8623522
[TBL] [Abstract][Full Text] [Related]
5. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
Uger RA; Barber BH
J Immunol; 1998 Feb; 160(4):1598-605. PubMed ID: 9469415
[TBL] [Abstract][Full Text] [Related]
6. Cells expressing an H chain Ig gene carrying a viral T cell epitope are lysed by specific cytolytic T cells.
Zaghouani H; Krystal M; Kuzu H; Moran T; Shah H; Kuzu Y; Schulman J; Bona C
J Immunol; 1992 Jun; 148(11):3604-9. PubMed ID: 1375250
[TBL] [Abstract][Full Text] [Related]
7. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies.
Anton LC; Yewdell JW; Bennink JR
J Immunol; 1997 Mar; 158(6):2535-42. PubMed ID: 9058784
[TBL] [Abstract][Full Text] [Related]
8. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.
Lawson CM; Bennink JR; Restifo NP; Yewdell JW; Murphy BR
J Virol; 1994 Jun; 68(6):3505-11. PubMed ID: 7514677
[TBL] [Abstract][Full Text] [Related]
9. A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes.
Fetten JV; Roy N; Gilboa E
J Immunol; 1991 Oct; 147(8):2697-705. PubMed ID: 1717574
[TBL] [Abstract][Full Text] [Related]
10. Both H-2- and non-H-2-linked genes influence influenza nucleoprotein epitope recognition by CD4+ T cells.
Brett SJ; Tite JP
Immunology; 1996 Jan; 87(1):42-8. PubMed ID: 8666434
[TBL] [Abstract][Full Text] [Related]
11. Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.
Berkhoff EG; de Wit E; Geelhoed-Mieras MM; Boon AC; Symons J; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Virol; 2005 Sep; 79(17):11239-46. PubMed ID: 16103176
[TBL] [Abstract][Full Text] [Related]
12. A nonimmunodominant nucleoprotein-derived peptide is presented by influenza A virus-infected H-2b cells.
Oukka M; Riché N; Kosmatopoulos K
J Immunol; 1994 May; 152(10):4843-51. PubMed ID: 8176207
[TBL] [Abstract][Full Text] [Related]
13. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
[TBL] [Abstract][Full Text] [Related]
14. Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties.
Bristol JA; Schlom J; Abrams SI
J Immunol; 1998 Mar; 160(5):2433-41. PubMed ID: 9498787
[TBL] [Abstract][Full Text] [Related]
15. Recognition of out-of-frame major histocompatibility complex class I-restricted epitopes in vivo.
Elliott T; Bodmer H; Townsend A
Eur J Immunol; 1996 May; 26(5):1175-9. PubMed ID: 8647184
[TBL] [Abstract][Full Text] [Related]
16. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
Rimmelzwaan GF; Boon AC; Voeten JT; Berkhoff EG; Fouchier RA; Osterhaus AD
Virus Res; 2004 Jul; 103(1-2):97-100. PubMed ID: 15163496
[TBL] [Abstract][Full Text] [Related]
17. The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained.
Wherry EJ; Puorro KA; Porgador A; Eisenlohr LC
J Immunol; 1999 Oct; 163(7):3735-45. PubMed ID: 10490969
[TBL] [Abstract][Full Text] [Related]
18. Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum.
Golovina TN; Wherry EJ; Bullock TN; Eisenlohr LC
J Immunol; 2002 Mar; 168(6):2667-75. PubMed ID: 11884431
[TBL] [Abstract][Full Text] [Related]
19. Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues.
Shastri N; Serwold T; Gonzalez F
J Immunol; 1995 Nov; 155(9):4339-46. PubMed ID: 7594593
[TBL] [Abstract][Full Text] [Related]
20. Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.
Potter P; Tourdot S; Blanchard T; Smith GL; Gould KG
J Gen Virol; 2001 May; 82(Pt 5):1069-1074. PubMed ID: 11297681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
